CORT
Corcept Therapeutics Incorporated
NASDAQ: CORT · HEALTHCARE · BIOTECHNOLOGY
$46.59
-0.06% today
Updated 2026-04-29
Market cap
$5.00B
P/E ratio
56.82
P/S ratio
6.57x
EPS (TTM)
$0.82
Dividend yield
—
52W range
$29 – $91
Volume
1.8M
Corcept Therapeutics Incorporated (CORT) Financial statements
SEC filings — annual and quarterly data.
Balance sheet — annual
| Item | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | $30.16M | $9.90M | $17.74M | $19.77M | $24.51M | $25.10M | $39.83M | $99.17M | $63.08M | $34.63M | $51.94M | $68.75M | $220.54M | $311.69M | $412.31M | $571.73M | $423.76M | $583.43M | $621.52M | $840.55M |
| Cash & equivalents | $3.82M | $8.91M | $11.43M | $14.72M | $23.87M | $24.58M | $39.63M | $93.03M | $54.88M | $24.25M | $40.44M | $51.54M | $104.03M | $206.76M | $31.27M | $476.89M | $77.62M | $66.33M | $135.55M | $127.67M |
| Current assets | $29.50M | $9.80M | $17.66M | $19.58M | $24.42M | $25.00M | $39.77M | $95.06M | $58.31M | $30.23M | $48.98M | $65.69M | $140.60M | $240.59M | $307.36M | $524.25M | $266.46M | $499.25M | $458.64M | $471.60M |
| Total liabilities | $3.56M | $3.54M | $3.01M | $2.87M | $2.42M | $3.86M | $5.03M | $37.39M | $42.06M | $38.02M | $33.44M | $27.37M | $29.57M | $35.81M | $41.13M | $48.39M | $47.95M | $81.59M | $114.81M | $160.96M |
| Current liabilities | $3.52M | $3.51M | $2.99M | $2.86M | $2.42M | $3.86M | $5.03M | $8.36M | $12.74M | $13.55M | $20.88M | $27.37M | $29.57M | $35.81M | $38.84M | $10.55M | $47.54M | $72.49M | $104.50M | $140.77M |
| Long-term debt | $42000.00 | $29000.00 | $16000.00 | $6000.00 | — | — | $0.00 | $29.03M | $29.32M | $24.46M | $12.56M | $0.00 | $0.00 | — | — | — | — | — | — | — |
| Shareholder equity | $26.59M | $6.36M | $14.73M | $16.91M | $22.09M | $21.24M | $34.81M | $61.78M | $21.02M | $-3.39M | $18.50M | $41.38M | $190.97M | $275.88M | $371.18M | $523.34M | $375.81M | $501.84M | $506.70M | $679.59M |
| Retained earnings | $-73.56M | $-98.44M | $-110.01M | $-130.07M | $-150.24M | $-176.20M | $-208.56M | $-246.61M | $-292.62M | $-324.00M | $-330.41M | $-322.27M | $-193.15M | $-117.74M | $-23.55M | $82.46M | $194.97M | $296.39M | $402.53M | $543.74M |
| Accounts receivable | — | — | — | — | — | — | — | $557000.00 | $1.43M | $3.33M | $6.22M | $9.86M | $28.20M | $17.59M | $19.93M | $26.20M | $29.02M | $46.86M | $56.82M | $58.08M |
| Inventory | — | — | — | — | — | — | $0.00 | $853000.00 | $1.10M | $1.21M | $1.68M | $2.33M | $8.38M | $16.24M | $5.42M | $21.16M | $4.99M | $6.10M | $7.73M | $12.41M |
| Goodwill | — | — | — | — | — | — | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | — | — | — | — | — | — | — |